DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Share Price

Certificat

DE000ME79EK7

Real-time Bid/Ask 17:03:10 03/07/2024 BST
89.5 EUR / 89.52 EUR -1.03% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.21%
1 month+2.10%
Date Price Change
03/07/24 89.56 -0.97%
02/07/24 90.44 -0.18%
01/07/24 90.6 -0.03%
28/06/24 90.63 +0.02%
27/06/24 90.61 -0.21%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 04:24 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN ME79EK
ISINDE000ME79EK7
Date issued 22/01/2024
Cap 100 $
Last trading day 20/12/2024
Maturity 20/12/2024 (170 Days)
Parity 1 : 1
Emission price 82.98
Emission volume N/A
Payment day 31/12/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 29.88 %
Sideways yield 3.468 %
Sideways yield pa 7.446 %
Outperformance point 142.6 $
Break even 96.65 €
Highest since issue 90.8
Lowest since issue 80.12
Spread 0.06
Spread %0.07%
Distance Cap 36.76 $
Distance Cap %+26.88%
Max. earning 3.104
Max. earning % 3.468 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus